# Individualizing Corticosteroid Use in Pneumonia

> **NCT05334316** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 24 (estimated)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT05334316
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-06
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05334316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05334316, "Individualizing Corticosteroid Use in Pneumonia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05334316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*